48.41EUR+3.00%Mkt Cap: 51.69B $P/E: —1d ago
Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil. It operates thro…
Industry Peers
Drug Manufacturers - Generalvs Drug Manufacturers - General
P/B
Cheaper
Div Yield
Higher
1M Perf
Lower
$1.07TUSDP/E 42.6
$611.36BUSDP/E 29.4
$444.21BUSDP/E 123.9
$308.01BUSDP/E 21.1
$317.37BUSDP/E 36.2
$281.52BUSDP/E 22.5
$275.65BUSDP/E 22.4
$269.91BUSDP/E 28.1
$237.69BUSDP/E 28.0
$202.85BUSDP/E 11.5
$195.44BUSDP/E 25.2
$156.86BUSDP/E 17.2
$137.24BUSDP/E 18.4
$117.66BUSDP/E 16.1
$97.68BUSDP/E 19.0
$86.27BUSDP/E 14.0
$31.90BUSDP/E 23.3
MRV
Marvell Technology, Inc.$30.93BUSDP/E 11.7
$11.35BUSDP/E 22.7
$11.02BUSDP/E 19.1
$10.98BUSDP/E 19.1
$6.60BUSDP/E 14.6
$3.56BUSDP/E 14.6
$3.03BUSDP/E 18.5
$54.86MUSD
$39.77MUSD
ELXR
Elixxer Ltd.$9.51MUSD
PHOO
Photocure ASA—
ROSE
DocMorris AG—
FLXN
Horizon Flexible Income ETF—P/E 27.2
CELG-RI
Bristol-Myers Squibb Company Ce—
Indicators:|
Key Statistics
Company
Market Cap51.69B $
Enterprise Value86.85B $
Revenue (TTM)49.18B $
Gross Profit29.11B $
Net Income (TTM)-3.93B $
Revenue/Share50.06 USD
Last Price48.41 EUR
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees87.8K
CountryDE
SectorHealthcare
IndustryDrug Manufacturers - General
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)10.35
PEG4.65
EV/EBITDA7.87
EV/Revenue1.77
P/S1.05
P/B1.65
EPS (TTM)-2.19
EPS (Forward)4.68
52W Range
24.8095% of range49.78
52W High49.78 EUR
52W Low24.80 EUR
Profitability
Gross Margin58.76%
Oper. Margin26.32%
EBITDA Margin22.45%
Profit Margin-7.94%
ROE-13.95%
ROA-3.46%
Growth
Revenue Growth-2.40%
Earnings Growth112.90%
Cash Flow & Leverage
Operating CF6.45B $
CapEx (TTM)2.70B $
FCF Margin16.17%
FCF Yield15.38%
Net Debt35.03B $
Net Debt/EBITDA3.17
Balance Sheet
Debt/Equity1.40
Current Ratio1.05
Quick Ratio0.69
Book Value/Sh29.36 EUR
Cash/Share6.779 EUR
Dividends
Fwd Div Rate0.1100 EUR
Trail. Div Rate0.1100 EUR
Div. Yield0.24%
5Y Avg Yield2.98%
Payout Ratio163.27%
Ex-Div DateApr 27, 2026
Pay Date—
Analyst Consensus
Rating1.8 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)51.64 EUR
Upside (mean)+6.7%
Target Range40.50 EUR – 65.00 EUR
€40.50+6.7% to mean€65.00
# Analysts18
Ownership
Shares Out.982.42M
Float982.42M
Insiders0.00%
Institutions61.24%
Technical
SMA 5038.02 (+27.3%)
SMA 20036.57 (+32.4%)
Beta0.84
S&P 52W Chg20.05%
Avg Vol (30d)3.59M
Avg Vol (10d)5.29M
Technical Indicators
RSI (14)83.4
MACD2.0933
MACD Signal0.6825
MACD Hist.+1.4108
BB Upper46.64 EUR
BB Middle38.14 EUR
BB Lower29.65 EUR
BB Width44.53%
ATR (14)1.875 EUR
Vol Ratio (20d)1.39x